6887 — Sunshine Lake Pharma Co Balance Sheet
0.000.00%
- HK$24.31bn
- HK$33.01bn
- CNY4.02bn
Annual balance sheet for Sunshine Lake Pharma Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|
| Period Length: | — | — | — |
| Source: | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Cash | |||
| Short Term Investments | |||
| Cash and Short Term Investments | 1,262 | 1,920 | 1,485 |
| Net Total Accounts Receivable | |||
| Net Total Receivables | 2,274 | 2,018 | 1,894 |
| Total Inventory | |||
| Prepaid Expenses | |||
| Total Other Current Assets | |||
| Total Current Assets | 4,151 | 6,412 | 4,979 |
| Gross Property, Plant And Equipment | |||
| Accumulated Depreciation | |||
| Net Property, Plant And Equipment | 4,003 | 4,180 | 4,391 |
| Net Intangible Assets | |||
| Long Term Investments | |||
| Other Long Term Assets | |||
| Total Assets | 10,689 | 12,658 | 11,932 |
| Accounts Payable | |||
| Accrued Expenses | |||
| Notes Payable / Short Term Debt | |||
| Current Portion of Long Term Debt / Capital Leases | |||
| Total Other Current Liabilities | |||
| Total Current Liabilities | 8,958 | 6,178 | 4,814 |
| Long Term Debt | |||
| Capital Lease Obligations | |||
| Total Long Term Debt | |||
| Total Debt | |||
| Minority Interest | |||
| Total Other Liabilities | |||
| Total Liabilities | 14,378 | 12,330 | 11,587 |
| Common Stock | |||
| Retained Earnings (Accumulated Deficit) | |||
| Treasury Stock | |||
| Other Equity | |||
| Total Equity | -3,689 | 328 | 344 |
| Total Liabilities & Shareholders' Equity | 10,689 | 12,658 | 11,932 |
| Total Common Shares Outstanding |